Clearside Biomedical Inc (CLSD)
1.02
-0.03
(-2.86%)
USD |
NASDAQ |
Nov 21, 16:00
1.02
0.00 (0.00%)
After-Hours: 07:47
Clearside Biomedical Shareholders Equity (Quarterly): -34.79M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -34.79M |
| June 30, 2024 | -28.28M |
| March 31, 2024 | -21.81M |
| December 31, 2023 | -15.91M |
| September 30, 2023 | -12.85M |
| June 30, 2023 | -4.973M |
| March 31, 2023 | 2.70M |
| December 31, 2022 | 10.61M |
| September 30, 2022 | 18.55M |
| June 30, 2022 | 25.25M |
| March 31, 2022 | 31.70M |
| December 31, 2021 | 37.98M |
| September 30, 2021 | 17.85M |
| June 30, 2021 | 19.34M |
| March 31, 2021 | 16.98M |
| December 31, 2020 | 8.763M |
| September 30, 2020 | 8.124M |
| June 30, 2020 | 7.287M |
| March 31, 2020 | 10.44M |
| Date | Value |
|---|---|
| December 31, 2019 | 11.16M |
| September 30, 2019 | 9.759M |
| June 30, 2019 | 12.90M |
| March 31, 2019 | 16.09M |
| December 31, 2018 | 23.62M |
| September 30, 2018 | 44.08M |
| June 30, 2018 | 66.67M |
| March 31, 2018 | 85.93M |
| December 31, 2017 | 21.42M |
| September 30, 2017 | 36.90M |
| June 30, 2017 | 54.33M |
| March 31, 2017 | 67.16M |
| December 31, 2016 | 71.66M |
| September 30, 2016 | 46.94M |
| June 30, 2016 | 45.90M |
| March 31, 2016 | 5.466M |
| December 31, 2015 | -36.66M |
| September 30, 2015 | -4.332M |
| December 31, 2014 | -19.21M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-34.79M
Minimum
Sep 2024
37.98M
Maximum
Dec 2021
5.405M
Average
9.602M
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 328.47M |
| Viking Therapeutics Inc | 911.45M |
| Atara Biotherapeutics Inc | -90.54M |
| Corvus Pharmaceuticals Inc | 12.41M |
| Crinetics Pharmaceuticals Inc | 832.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.16M |
| Total Liabilities (Quarterly) | 63.95M |
| Current Ratio | 4.490 |